Bailard’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,929
| Closed | -$226K | – | 696 |
|
|
2022
Q1 | $226K | Sell |
2,929
-586
| -17% | -$45.2K | 0.01% | 632 |
|
|
2021
Q4 | $311K | Buy |
+3,515
| New | +$311K | 0.01% | 522 |
|
|
2021
Q3 | – | Sell |
-4,000
| Closed | -$334K | – | 711 |
|
|
2021
Q2 | $334K | Hold |
4,000
| – | – | 0.01% | 490 |
|
|
2021
Q1 | $302K | Hold |
4,000
| – | – | 0.01% | 516 |
|
|
2020
Q4 | $351K | Hold |
4,000
| – | – | 0.02% | 404 |
|
|
2020
Q3 | $304K | Hold |
4,000
| – | – | 0.02% | 387 |
|
|
2020
Q2 | $493K | Hold |
4,000
| – | – | 0.03% | 271 |
|
|
2020
Q1 | $338K | Hold |
4,000
| – | – | 0.02% | 287 |
|
|
2019
Q4 | $338K | Hold |
4,000
| – | – | 0.02% | 381 |
|
|
2019
Q3 | $270K | Hold |
4,000
| – | – | 0.02% | 422 |
|
|
2019
Q2 | $343K | Hold |
4,000
| – | – | 0.02% | 381 |
|
|
2019
Q1 | $355K | Sell |
4,000
-1,000
| -20% | -$88.8K | 0.02% | 378 |
|
|
2018
Q4 | $426K | Hold |
5,000
| – | – | 0.03% | 334 |
|
|
2018
Q3 | $485K | Hold |
5,000
| – | – | 0.03% | 383 |
|
|
2018
Q2 | $471K | Buy |
5,000
+1,000
| +25% | +$94.2K | 0.03% | 378 |
|
|
2018
Q1 | $324K | Sell |
4,000
-100
| -2% | -$8.1K | 0.02% | 399 |
|
|
2017
Q4 | $366K | Buy |
+4,100
| New | +$366K | 0.02% | 350 |
|
|
2016
Q1 | – | Sell |
-2,000
| Closed | -$210K | – | 264 |
|
|
2015
Q4 | $210K | Buy |
+2,000
| New | +$210K | 0.09% | 188 |
|